Histamine Intolerance, Hypermobility (hEDS) and POTS: The Chronic Illness Triad

If you've spent any time in chronic illness communities lately, you've probably seen it. A short video explains how three conditions seem to overlap. A long Reddit thread lists symptoms that sound uncomfortably familiar. A patient forum post asks whether anyone else reacts to food, faints when they stand, and bruises easily. 

Then someone names the pattern.

Many people now call it the triad: hypermobile Ehlers-Danlos syndrome (hEDS), postural orthostatic tachycardia syndrome (POTS) and mast cell activation syndrome (MCAS). Much of that conversation focuses on histamine intolerance hypermobility links, which is one reason the topic has taken off. Interest in mcas pots eds content keeps growing, and it shows no sign of slowing.

I've spent a lot of time reading the research behind these conversations and I want to be upfront about something: the science connecting these conditions is still young, and parts of it are contested. Some online claims go further than the evidence allows. Other claims point to real questions worth asking. My aim is simple. I'll walk through the theories, the studies and the gaps in plain language, so you can judge for yourself.

Why the Histamine Intolerance, Hypermobility (hEDS) and POTS Triad Is Everywhere Right Now

Chronic illness often comes with a long wait for answers. Many people see several doctors before anyone takes their symptoms seriously. Some hear their pain is stress, or that their fainting is anxiety. That experience leaves a mark.

Online communities fill that gap. They share symptoms, lab results and what worked. They also offer something mainstream health content rarely does: a sense that you're not imagining things. That matters. It's a big reason these conversations travel so quickly.

Pattern-spotting is also a natural human habit. When a condition has no clear test and no clear cause, people look for connections, similarities. Sometimes those are real. Sometimes they are coincidences that feel meaningful. Good science sorts one from the other, and unfortunately, that takes time.

Get the free diet guide!

Meet the Three Conditions: MCAS, POTS, EDS

Mast Cell Activation Syndrome

Mast cells are immune cells found throughout the body, especially in the skin, gut and airways. When they activate, they release histamine and other chemical messengers. That's helpful during an allergic reaction. It's less helpful when it happens too often or without a clear trigger.

MCAS describes recurring episodes of mast cell activation affecting two or more organ systems. Symptoms should respond to treatments that block mast cell chemicals or prevent their release. [1] That definition sounds clear, but it's one reason MCAS remains debated. Clinicians don't always agree on how to confirm it.

Postural Orthostatic Tachycardia Syndrome

POTS is a condition of the autonomic nervous system. That system runs the things you don't think about, like heart rate and blood pressure. In POTS, standing up triggers an unusually large jump in heart rate. For adults, that generally means an increase of 30 beats per minute or more within 10 minutes of standing, without a significant drop in blood pressure.

The result can be dizziness, palpitations, brain fog and exhaustion. Some people feel close to fainting. Others struggle to stand through a shower or a trip to the grocery store.

Hypermobile Ehlers-Danlos Syndrome

hEDS is a connective tissue disorder. Connective tissue supports your joints, skin and blood vessels. In hEDS, that support works differently. People often have generalized joint hypermobility, joint instability and chronic pain. Skin can feel soft and stretchy, and bruising can come easily. [2]

Here's the tricky part. Most other types of Ehlers-Danlos syndrome have a known genetic cause. hEDS does not. Doctors diagnose it mostly by clinical criteria, which means the picture is built from history and examination rather than a single lab test. That makes research harder, and it leaves many people with a diagnosis that still feels uncertain.

Working Through the Proposed MCAS, POTS, EDS Connections

No one has shown that these three conditions share a single cause. Still, several theories have been proposed. Here are the main ones, in plain language.

Fragile Tissue and Reactive Cells

One idea starts with connective tissue. If tissue is more fragile, it may be more prone to low-grade inflammation. Inflammation could, in theory, keep mast cells on alert. [2] A review of the literature describes how mast cell mediators may disrupt connective tissue integrity. That's a plausible mechanism. It's still a hypothesis that needs direct testing.

Blood Vessels and the Autonomic System

Mast cell chemicals can affect blood vessels. They may influence how vessels widen or narrow, and how much fluid the body holds. Some researchers wonder whether that could contribute to POTS symptoms in certain people. Again, this is an idea worth studying, not a settled answer.

Histamine and the Gut

Histamine intolerance is a related but separate concept. The body normally breaks down histamine with enzymes. The main one in the gut is diamine oxidase, often called DAO. If DAO activity is low, histamine from food may build up. [3] Histamine intolerance is generally described as an impaired ability to metabolize ingested histamine.

A 2025 review links insufficient DAO activity with migraines, gut disturbances and allergy-like reactions. [4] That's a useful overview. But it's also a review, which means it summarizes evidence rather than settling it.

This is where the hEDS histamine question comes in. Many people with hEDS report food sensitivities, flushing and digestive trouble. Some assume histamine is the reason. The link is plausible, and some clinicians are exploring it. Still, large, well-designed trials are limited. That's an honest gap in the evidence, and it's worth saying out loud.

Get the free diet guide!

Connecting MCAS, POTS, EDS: What the Research Actually Shows 

Studies That Point Toward Overlap

The histamine intolerance hypermobility question is harder to answer than it looks. Research on overlap is still early, but some studies do suggest these conditions cluster together. A 2025 retrospective review looked at 100 young patients who met POTS criteria. Researchers checked how often hypermobility spectrum disorder, hEDS and MCAS showed up. [5] Their key finding was that prevalence and overlap depend heavily on which definitions are used. Strict definitions may miss people who clearly need care.

Clinical reviews describe a similar pattern. [6] One multisystem analysis notes that hEDS frequently coexists with POTS, MCAS, and autoimmune and allergic conditions. That's a strong signal that many patients carry more than one diagnosis. It doesn't prove that one condition causes another.

The Case Against a Single Triad

A critical review by Kucharik and Chang took a hard look at this literature. [7] Across two search strategies, the authors found few original research articles. None of the papers they identified combined all three conditions in a single study. Their conclusion was blunt. Current evidence doesn't yet establish MCAS or hEDS as separate, significant clinical entities. They also described all three conditions as controversial, either in their existence or their cause.

Now, it’s important to note the authors don't say these patients are imagining things. Instead, they say science hasn't caught up. That's a really important distinction. 

A systematic review using PRISMA guidelines reached a similar view of the evidence base. [8] Only a small number of papers directly examined associations between these conditions, and many of the links remain untested in larger groups.

Where Clinicians Stand Today on the MCAS, POTS, EDS Link

Clinicians are still working the details out when it comes to the MCAS, POTS, EDS link. [9] A 2025 AGA clinical practice update covers gut symptoms in people with hEDS or hypermobility spectrum disorders. It advises targeted testing. Universal testing for POTS or MCAS in everyone with hEDS is not supported by current evidence. In other words, a hEDS diagnosis alone doesn't automatically mean you need every test on the list.

Why Testing Is Tricky

Tryptase blood tests are often used to look for mast cell activation. Ideally, samples are taken at baseline and again one to four hours after a flare. The AGA update describes a rise of 20% above baseline, plus 2 ng/mL, as evidence of activation. [9] But flares are unpredictable. Many people can't get a sample at the right moment. A normal result between flares doesn't always settle the question.

Histamine Testing and Diets

Testing for histamine intolerance is also limited. Low-histamine diets help some people, but they are restrictive. Cutting out whole food groups can lead to nutrient gaps and added stress around eating. If you try one, work with a clinician or registered dietitian. Agree on a time frame and track what changes.

Common Symptoms People Report Across the Triad of MCAS, POTS, EDS

People often describe a mix of symptoms that overlap. Joint pain and instability are common in hEDS. Lightheadedness, a racing heart and fatigue show up in POTS. Flushing, hives, itching, headaches and digestive upset come up often in mast cell and histamine conversations. Many people also mention brain fog, poor sleep and anxiety. Each of these symptoms has many possible causes. That's why a single symptom rarely points to a single condition. A pattern is a good reason to see a doctor, but it isn't a diagnosis on its own.

Three Myths Worth Clearing Up When Assessing MCAS, POTS, EDS

A few hEDS histamine myths come up again and again. They sound logical, which is exactly why they spread.

Myth #1: Histamine Causes Everything

Histamine plays a role in many body functions, but it doesn't explain every symptom. Stress, infections, hormones, medications and many other factors can cause similar complaints. Blaming histamine for everything can delay other answers.

Myth #2: Having hEDS Means You Have MCAS

It doesn't. Some people with hEDS have symptoms that suggest mast cell involvement. Others don't. The AGA update advises against universal testing for this reason. The two conditions can overlap, but they are not the same thing.

Myth #3: One Test Settles It

No single test diagnoses MCAS, POTS or histamine intolerance on its own. Diagnosis usually combines history, symptoms, physical examination and targeted tests. A careful evaluation is more useful than one dramatic result.

Four Practical Steps for Living with Symptoms of MCAS, POTS, EDS

Step #1: Keep a Symptom Log

Write down symptoms, foods, sleep, medications, stress and activity. Note the time and severity. Patterns can show up over weeks that you would otherwise miss. Bring the log to your appointments. It gives your clinician something concrete to work with.

Step #2: Ask Good Questions

Ask which conditions have been ruled out, why a particular test is recommended and what would change the plan. These questions keep the conversation focused and collaborative.

Step #3: Watch for Red Flags

Seek urgent care for chest pain, fainting with an injury, trouble breathing, swelling of the face or throat, or a severe allergic reaction. Don't wait for a specialist appointment for any of those.

Step #4: Be Wary of Quick Fixes

Poorly researched supplement suggestions, strict elimination diets and expensive tests sold online can look appealing. Some people do find relief, but the promise of a quick fix is typically not a promise you want to trust. Ask what evidence supports a product, what the risks are and whether it interacts with your medications. Always consider what the supplement is going to address. 

If you’re trying to manage your histamine levels while trying to figure out your related symptoms for example, ask the following about potential supplements:

• Is it going to help you manage histamine levels in the gut through modulation of DAO, or 
  
  
• Will it provide mast cell stabilization using a low histamine combination product that has antihistamine properties?

Both of these are well-researched effects in helping to manage histamine intolerance and mast cell activation. 

Get the free diet guide!

 

MCAS, POTS, EDS: The Bottom Line

The triad is a real conversation, and it reflects real experiences. The symptoms people describe are not made up. While the science connecting hEDS, POTS, MCAS and histamine is still developing, some connections look plausible. But let's be real; others remain unproven or contested.

Treat the triad as a working hypothesis, not a settled diagnosis. Stay curious. Ask for careful evaluation. And keep checking what you read against the research as it evolves, including what you read here.

References

1. Monaco A, Choi D, Uzun S, Maitland A, Riley B. Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature. Immunol Res. 2022 Aug;70(4):419-431.
2. Malfait F, et al. Hypermobile Ehlers-Danlos Syndrome. In: GeneReviews [Internet]. Seattle (WA): University of Washington; updated. PubMed ID: 20301456.
3. Comas Basté O, Sánchez Pérez S, Veciana Nogués MT, Latorre Moratalla M, Vidal Carou MC. Histamine Intolerance: The Current State of the Art. Biomolecules. 2020;10(8):1181. 
4. Alemany-Fornés M, Bori J, Muguerza B, Suárez M. Diamine oxidase deficiency implications for health, current management, and future directions in the treatment of histamine intolerance: A review. Int J Biol Macromol. 2025 Oct;327(Pt 1):147130.
5. Yao L, Subramaniam K, Raja KM, Arunachalam A, Tran A, Pandey T, Ravishankar S, Suggala S, Hendrickson C, Maxwell AJ. Association of postural orthostatic tachycardia syndrome, hypermobility spectrum disorders, and mast cell activation syndrome in young patients; prevalence, overlap and response to therapy depends on the definition. Front Neurol. 2025 Apr 25;16:1513199.
6. Tanuku S, Baer T, Viswanath O, Ganti L. The Expanding Multisystem Research Landscape of Hypermobile Ehlers-Danlos Syndrome: An Analysis of Orthopedic, Autonomic, Immunologic, and Neuropsychiatric Comorbidities. Orthop Rev (Pavia). 2026 Sep 16;18:169727.
7. Kucharik AH, Chang C. The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS). Clin Rev Allergy Immunol. 2020 Jun;58(3):273-297. 
8. Bruessel P, Govender M, Frahm-Jensen G. The Investigation and Management of the Abdominopelvic Vascular Compression Syndromes in Patients with Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorder. Vasc Health Risk Manag. 2026;22:592420
9. Aziz Q, Harris LA, Goodman BP, Simrén M, Shin A. AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review. Clin Gastroenterol Hepatol. 2025 Jul;23(8):1291-1302.